secwatch.observer — SEC 8-K summary
======================================

Issuer:     Citius Pharmaceuticals, Inc. (CTXR)
CIK:        0001506251
Form:       8-K
Filed at:   2024-12-20T23:59:59+00:00
Accession:  0001213900-24-111212
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Pharmaceuticals regains Nasdaq compliance on bid price rule
------------------------------------------------------------------

- Received Nasdaq notice on Dec 18, 2024 confirming compliance with Listing Rule 5550(a)(2).
- Stock closed at $1.00 or more for 12 consecutive trading days from Nov 26 to Dec 12, 2024.
- Nasdaq stated the matter is now closed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506251/000121390024111212/0001213900-24-111212-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506251/000121390024111212/ea0225393-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-111212

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer